Skip to content
Animal Animal WelfareRights, Finance Investment

Mad Paws (ASX:MPA) Delivers Positive Cash EBITDA & Strong Growth in 1H FY25

Jane Morgan Management 2 mins read

MEDIA RELEASE

Mad Paws (ASX:MPA) Reports Positive Cash EBITDA and Strong Marketplace Growth in 1H FY25

Sydney, Australia – 27 February 2025 – Mad Paws Holdings Limited (ASX:MPA), Australia’s leading online pet ecosystem, has reported a positive Cash EBITDA of $0.3 million for the first half of FY25, marking a 172% improvement compared to the prior corresponding period (pcp). This result underscores the company’s strong focus on profitability, operational efficiencies, and strategic brand-building efforts.

1H FY25 Financial Highlights:

  • Group Operating Revenue of $14.7 million, flat on pcp, but up 11% excluding Sash and Waggly.

  • Marketplace Operating Revenue of $4.8 million, up 12% on pcp.

  • E-Commerce Revenue of $9.9 million, down 5% on pcp, but up 11% excluding Sash and Waggly.

  • Segment Operating EBITDA positive at $2.2 million, up 76% on pcp.

  • Marketplace Cash EBITDA of $2.2 million, with an EBITDA margin of 45.8%.

  • E-commerce & Subscription Cash EBITDA break-even, improving by $0.5 million.

  • Operating cash flow of $0.8 million, with a $4.0 million cash balance.

Growth Strategy and Market Positioning
Mad Paws continues to strengthen its market leadership by leveraging its proprietary pet data, enhancing customer experience, and optimizing operational efficiencies. The company successfully deployed $2.1 million of Seven West Media (SWM) marketing contra, with $1.9 million remaining for H2 FY25 to further accelerate growth. Despite a 9% year-on-year decline in Google search volume trends, the company’s above-the-line marketing campaign has driven higher website sessions and increased new customer acquisition.

CEO Justus Hammer commented: “This half-year has been a defining period for Mad Paws as we navigate challenging market conditions while driving revenue growth and profitability. Our strategic focus on performance initiatives in e-commerce and marketplace segments has yielded strong financial results. We remain committed to further improving EBITDA, leveraging data-driven insights, and maximizing shareholder value.”

Operational Efficiencies and Future Outlook

  • AI-driven automation continues to enhance prescription processing and customer service, reducing costs and improving efficiency.

  • Pet Chemist revenue grew by 9%, reflecting strong customer retention and demand for core medication products.

  • Media revenues surged 92%, reaching $0.3 million, highlighting new high-margin growth avenues.

  • Marketplace transactions increased 5%, while average booking values rose 6%.

Building on this momentum, Mad Paws is well-positioned for further expansion, with a focus on closing the valuation gap with global peers and enhancing shareholder returns.

 

 


About us:

About Mad Paws (ASX:MPA)
Mad Paws Holdings Limited operates Australia’s leading online pet ecosystem, offering trusted pet services, products, and pharmacy solutions. With over 300,000 active pet owners and 400,000 annual transactions, the company is committed to delivering premium pet care solutions within the $30 billion Australian pet market.


Contact details:

Jane Morgan
Investor & Media Relations
Email: [email protected]
Phone: +61 405 555 618

Media

More from this category

  • Animal Animal WelfareRights, Indigenous
  • 16/03/2026
  • 16:00
Coalition Against Duck Shooting

Premier Jacinta Allan will have the blood of some 300,000 native waterbirds on her hands following this year’s duck shooting season.

Rescuers will be on the Kerang wetlands in north west Victoria Laurie Levy, Campaign Director, today said: “The late 1950s Liberal Premier Sir Henry Bolte would today be proud of Victoria’s Left-leaning Labor Premier Jacinta Allan who will again have the blood of some 300,000 native waterbirds on her hands”. “Allowing a duck shooting season to proceed following Victoria’s bushfires that took a terrible toll of Victoria’s native wildlife, Premier Allan has again bowed to the wishes of a dwindling number of duck shooters, who make up less than 0.2 per cent of all Victorians and her two powerful Union…

  • Biotechnology, Finance Investment
  • 16/03/2026
  • 14:38
Jane Morgan Management

BlinkLab Limited (ASX:BB1) Completes Clinical Trial Network for Pivotal FDA Study with Tenth U.S. Site Onboarded

16 March 2026 – Perth, Australia | BlinkLab Limited (ASX:BB1) has completed the clinical site network for its pivotal U.S. FDA 510(k) study of BlinkLab Dx 1, with the University of Arkansas joining as the tenth and final participating site. The milestone completes the onboarding of all clinical centres for the Company’s pivotal study of its smartphone-based diagnostic aid for autism, positioning BlinkLab to begin first patient testing later this month and commence the main study phase in the first quarter of 2026. The FDA-endorsed pivotal trial is designed to validate both the usability and diagnostic accuracy of BlinkLab Dx…

  • Contains:
  • Finance Investment
  • 16/03/2026
  • 13:00
First Super

First Super appoints Greg Everett as Acting CEO

First Super is pleased to announce the appointment of Greg Everett as Acting CEO, effective 16 March 2026. Greg steps into the acting role following Bill Watson’s resignation in early January. First Super’s Co-Chairs, Mike Radda and Denise Campbell-Burns, said Greg was well-placed to drive First’s strategy and maintain member focus. “Greg and the executive will maintain momentum, deliver our strategy and support operations through this transition period,” Mike Radda said. Greg joined First Super as Deputy CEO in November, bringing with him more than 20 years of superannuation experience, including CEO of the Superannuation Trustee Office for Guild Group,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.